EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ferrocene thiazolidine-2,4-dione derivatives cause DNA damage and interfere with DNA repair in triple-negative breast cancer cells

Nyeleti Vukea iD, Ogunyemi Oderinlo, Matshawandile Tukulula iD, Setshaba David Khanye iD, Adrienne Lesley Edkins iD, Jo-Anne de la Mare iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0328155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Nyeleti Vukea und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Microbiology and Bioinformatics, Rhodes University, Makhanda (Grahamstown), South Africa. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, DNA Damage, DNA Repair, Ferrous Compounds. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation, Rhodes University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, ferrocene-containing thiazolidine-2,4-dione derivatives were screened against triple-negative breast cancer (TNBC) cell lines, which represent an aggressive subtype of the disease predominant in women of African descent. The lack of key receptors in TNBC poses a therapeutic challenge as there are limited targeted treatment options available for this subtype. The ferrocene thiazolidine-2,4-dione derivatives displayed toxicity against HCC70 TNBC cells in the low-moderate micromolar range (5–46 μM) and two compounds were selected for further study, with IC 50 values of 7.54 ± 1.07 μM (OY25) and 5.59 ± 1.24 μM (OY29). Additionally, compounds OY25 and OY29 were screened against other cancer and non-tumourigenic cell lines and found to be less toxic against non-cancerous breast epithelial cell line MCF-12A (SI = 2.2188 and 4.4359, respectively) compared to the HCC70 TNBC cell line. Compounds OY25 and OY29 show a dual mode of action involving increased reactive oxygen species generation and induction of DNA damage. In silico docking analysis and competitive DNA binding fluorescence-based assays revealed that the compounds disrupt key DNA damage phosphoprotein levels through binding to the minor groove of DNA. In a combination assay, the compounds acted synergistically and antagonistically with DNA damage-inducing drugs, camptothecin and etoposide, respectively. Meanwhile, in combination with PARP-1 inhibitor, OY25 and OY29 acted synergistically and antagonistically, respectively. Furthermore , in silico results, using the SwissADME web tool, showed that the compounds OY25 and OY29 display desirable ADME (absorption, distribution, metabolism, and excretion) profile with parameters within acceptable range.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsDNA DamageDNA RepairFerrous CompoundsThiazolidinedionesAntineoplastic AgentsMetallocenesHumansCell Line, TumorFemaleMolecular Docking SimulationReactive Oxygen Species

Substanzen

Ferrous CompoundsThiazolidinedionesAntineoplastic AgentsMetallocenesthiazolidine-2,4-dioneferroceneReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Biochemistry, Microbiology and Bioinformatics, Rhodes University, Makhanda (Grahamstown), South Africa.
  • Department of Chemistry, Rhodes University, Makhanda (Grahamstown), South Africa.
  • Department of Chemistry, Federal University, Otuoke, Bayelsa State, Nigeria.
  • School of Chemistry and Physics, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Durban, South Africa.
  • Division of Pharmaceutical Chemistry, Rhodes University, Makhanda (Grahamstown), South Africa.

ORCID-Profile: Nyeleti Vukea, Matshawandile Tukulula, Setshaba David Khanye, Adrienne Lesley Edkins, Jo-Anne de la Mare

Förderung

  • National Research Foundation
  • South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation
  • Rhodes University

Zitieren

APA

Vukea, N., Oderinlo, O., Tukulula, M., Khanye, S. D., Edkins, A. L., & de la Mare, J. A. (2025). Ferrocene thiazolidine-2,4-dione derivatives cause DNA damage and interfere with DNA repair in triple-negative breast cancer cells. PLOS One. https://doi.org/10.1371/journal.pone.0328155

Vancouver

Vukea N, Oderinlo O, Tukulula M, Khanye SD, Edkins AL, de la Mare JA. Ferrocene thiazolidine-2,4-dione derivatives cause DNA damage and interfere with DNA repair in triple-negative breast cancer cells. PLOS One. 2025. doi:10.1371/journal.pone.0328155

BibTeX
@article{Vukea2025,
  author = {Vukea, Nyeleti and Oderinlo, Ogunyemi and Tukulula, Matshawandile and Khanye, Setshaba David and Edkins, Adrienne Lesley and de la Mare, Jo-Anne},
  title = {Ferrocene thiazolidine-2,4-dione derivatives cause DNA damage and interfere with DNA repair in triple-negative breast cancer cells},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0328155}
}
Kostenlos starten →